The Mediterranean diet also wins gold medals for healthy weight loss and lowering obesity. Obesity is a leading risk factor for cancer and many other chronic diseases such as type 2 diabetes, heart ...

Eli Lilly has cut the price for vials of its weight-loss drug Zepbound sold online and expanded the range of doses in an ...

The NHS medical director has cautioned about the side effects of certain medications following the latest findings ...

Guggenheim analyst sees significant upside in Metsera stock to $56. MTSR is working on both injectable and oral weight-loss ...

Eli Lilly said it has launched new doses of its obesity treatment drug and reduced its prices.

Metformin is an old drug. In its earliest form, it was an extract from lilacs and was purportedly used in the 1700s to treat ...

Evercore ISI analyst Umer Raffat initiated coverage of Metsera (MTSR) with an Outperform rating. Metsera has a full portfolio of GLP-1 ...

BofA initiated coverage of Metsera (MTSR) with a Buy rating and $38 price target implying over 20% share upside. Metsera is a clinical-stage ...